- Home
- Our jobs
- CAMS
- Hua Medicine
- Daiichi Sankyo (China)
- Zhongda Hospital
- SDFMU & SAMS
- Jilin Cancer Hospital
- Peking University Cancer Hospital
- Nanjing Medical University
- Taikang Healthcare
- SAHZU
- JSPH
- Ruijin Hospital
- Guangdong Provincial People's Hospital
- Renji Hospital
- ZJUSS
- CSCO
- Zhongshan Hospital
- PUMCH
- SNPH
- ZUCH
- Qilu Hospital
- SUSTC
- Jiahui
- FAHZU
- Yitu Tech
Hua Medicine
Hua Medicine is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong, China. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing ( 华堂宁®) (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in patients with type 2 diabetes, and stabilizes imbalances in blood glucose levels in patients.